Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ACER

Acer Therapeutics (PK) (ACER)

Acer Therapeutics Inc (PK)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:ACER
DateTimeSourceHeadlineSymbolCompany
11/30/20237:30AMEdgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]USOTC:ACERAcer Therapeutics Inc (PK)
11/27/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessUSOTC:ACERAcer Therapeutics Inc (PK)
11/27/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessUSOTC:ACERAcer Therapeutics Inc (PK)
11/20/20235:09PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACERAcer Therapeutics Inc (PK)
11/20/20235:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACERAcer Therapeutics Inc (PK)
11/20/20235:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACERAcer Therapeutics Inc (PK)
11/20/20235:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACERAcer Therapeutics Inc (PK)
11/20/20235:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACERAcer Therapeutics Inc (PK)
11/20/20235:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACERAcer Therapeutics Inc (PK)
11/20/20234:51PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:ACERAcer Therapeutics Inc (PK)
11/20/20234:43PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:ACERAcer Therapeutics Inc (PK)
11/20/20234:42PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:ACERAcer Therapeutics Inc (PK)
11/20/20234:41PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:ACERAcer Therapeutics Inc (PK)
11/20/20234:41PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:ACERAcer Therapeutics Inc (PK)
11/20/20234:40PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:ACERAcer Therapeutics Inc (PK)
11/20/20234:39PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:ACERAcer Therapeutics Inc (PK)
11/20/20234:39PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:ACERAcer Therapeutics Inc (PK)
11/20/20234:38PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:ACERAcer Therapeutics Inc (PK)
11/20/20234:38PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:ACERAcer Therapeutics Inc (PK)
11/20/20234:37PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:ACERAcer Therapeutics Inc (PK)
11/20/20234:37PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:ACERAcer Therapeutics Inc (PK)
11/20/20234:35PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:ACERAcer Therapeutics Inc (PK)
11/20/20234:32PMEdgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementUSOTC:ACERAcer Therapeutics Inc (PK)
11/20/20234:31PMEdgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementUSOTC:ACERAcer Therapeutics Inc (PK)
11/20/20234:26PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:ACERAcer Therapeutics Inc (PK)
11/20/20238:49AMEdgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesUSOTC:ACERAcer Therapeutics Inc (PK)
11/14/20236:04AMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ACERAcer Therapeutics Inc (PK)
01/03/20204:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ACERAcer Therapeutics Inc (PK)
01/03/20204:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ACERAcer Therapeutics Inc (PK)
01/03/20204:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ACERAcer Therapeutics Inc (PK)
 Showing the most relevant articles for your search:USOTC:ACER